# Seeking Alpha * **Definition:** Seeking Alpha is a financial news and analysis platform that provides crowdsourced content from investors and industry experts, focusing on stock market insights, investment research, and financial analysis. * **Taxonomy:** Key Sources / US National / Seeking Alpha ## News * Selected news from the source **Seeking Alpha**, for healthcare technology leaders * 4.8K news items are in the system for this source * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Topics | | --- | --- | --- | | 5/27/2025 | [**NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study**](https://seekingalpha.com/pr/20116328-neuropace-announces-preliminary-results-from-one-year-data-in-nautilus-study) | [[Clinical Data]] | | 5/20/2025 | [**Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer**](https://seekingalpha.com/pr/20110428-petros-pharmaceuticals-partners-with-innolitics-a-leading-software-as-a-medical-device) | [[Medical Device]]; [[Medical Software]]; [[Pharma]] | | 5/20/2025 | [**CooperCompanies' 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet**](https://seekingalpha.com/pr/20111086-coopercompanies-2024-sustainability-report-showcases-efforts-that-benefit-people-and-the) | [[Privacy and Security]]; [[Sustainability]] | | 5/20/2025 | [**Avant Technologies and Ainnova in Talks to Obtain Innovative Technology in Preventative ...**](https://seekingalpha.com/pr/20109875-avant-technologies-and-ainnova-in-talks-to-obtain-innovative-technology-in-preventative) | [[Early Disease Detection]] | | 5/19/2025 | [**TruBridge Announces Next Step of Collaboration With Microsoft, Enhancing Community ...**](https://seekingalpha.com/pr/20108652-trubridge-announces-next-step-of-collaboration-with-microsoft-enhancing-community-healthcare) | [[Operational Efficiency]]; [[Healthcare]]; [[Electronic Medical Record]] | | 5/14/2025 | [**Luminar signals 100evenue growth for 2025 while appointing new CEO Paul Ricci amid leadership transition**](https://seekingalpha.com/news/4448469-luminar-signals-10-percentminus-20-percent-revenue-growth-for-2025-while-appointing-new-ceo) | [[Leadership Changes]] | | 5/14/2025 | [**Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First ...**](https://seekingalpha.com/pr/20104564-vaxart-publishes-positive-complete-data-from-a-phase-2b-challenge-study-of-its-first) | [[Vaccine Development]] | | 4/29/2025 | [**Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing ...**](https://seekingalpha.com/pr/20082971-abbott-integrates-libres-data-with-epics-electronic-health-record-system-providing-healthcare) | [[Patient Engagement Technology]]; [[Data Management]]; [[Critical Care]] | | 4/25/2025 | [**Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region**](https://seekingalpha.com/pr/20079410-claritev-and-burjeel-holdings-partner-to-advance-revenue-integrity-solutions-in-the-mena) | [[AI in Revenue Cycle Management]]; [[AI in Medicine]]; [[Claims Processing]] | | 4/17/2025 | [**CareCloud to Announce First Quarter 2025 Results on May 6, 2025 - Seeking Alpha**](https://seekingalpha.com/pr/20070423-carecloud-to-announce-first-quarter-2025-results-on-may-6-2025) | [[EHR]]; [[Digital Health Innovations]]; [[Digital Health]] | | 2/12/2025 | [**Trump, Putin agree to 'start negotiations immediately' over Russia and Ukraine**](https://seekingalpha.com/news/4407064-trump-putin-agree-to-start-negotiations-immediately-over-russia-and-ukraine) | [[Negotiation]]; [[Negotiations]] | | 2/5/2025 | [**J.P. Morgan Healthcare Conference 2025: Healthcare's Roadmap For The Year Ahead**](https://seekingalpha.com/article/4754944-jp-morgan-healthcare-conference-2025-healthcare-roadmap-year-ahead) | [[Generative AI Adoption]]; [[AI-Driven Tools]]; [[Financial Constraints]] | | 1/21/2025 | [**Tempus AI Has A High Probability Of Profitability In 2025**](https://seekingalpha.com/article/4750935-tempus-ai-has-a-high-probability-of-profitability-in-2025) | [[Medical Device]]; [[Collaboration]]; [[Pharma]] | | 1/15/2025 | [**Healwell AI: Buy This AI Penny Stock Before The Rush**](https://seekingalpha.com/article/4749740-healwell-ai-buy-this-ai-penny-stock-before-the-rush) | [[AI Health Assistants]]; [[Mergers]]; [[Acquisition]] | | 1/8/2025 | [**Endava PLC: Long-Term Growth Potential Is The Key Focus**](https://seekingalpha.com/article/4748434-endava-stock-long-term-growth-potential-key-focus) | [[AI in Claims Processing]]; [[AI and Machine Learning]]; [[Integration of AI and IoT]] | | 1/4/2025 | [**We See Further Recovery For Lantronix (NASDAQ:LTRX) - Seeking Alpha**](https://seekingalpha.com/article/4747639-we-see-further-recovery-for-lantronix) | [[Operational Efficiency]]; [[Compliance]] | | 12/29/2024 | [**Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025 (NASDAQ:CRSP)**](https://seekingalpha.com/article/4746851-crispr-therapeutics-stock-from-casgevy-success-to-catalyst-rich-2025) | [[Oncology]]; [[Investment Management]]; [[Biotech]] | | 12/29/2024 | [**Ocular Is Now Thoroughly Derisked (NASDAQ:OCUL) - The Total Pharma Tracker**](https://seekingalpha.com/mp/1202-the-total-pharma-tracker/articles/6102781-ocular-is-now-thoroughly-derisked) | [[Gene Therapies]]; [[Pharma]] | | 12/26/2024 | [**Top Stocks For Tech-Driven Consumer Trends - Seeking Alpha**](https://seekingalpha.com/article/4746110-top-stocks-for-tech-driven-consumer-trends) | [[AI and Automation]]; [[AI and Data Analytics]]; [[Technological Advancements]] | | 12/23/2024 | [**Five Reasons Why You Should Invest In Small Caps Right Now - Seeking Alpha**](https://seekingalpha.com/article/4745694-five-reasons-why-you-should-invest-in-small-caps-right-now) | [[Portfolio Management]] | | 12/9/2024 | [**Hong Kong Pharma Digital Technology Aims For $5 Million Micro IPO - Seeking Alpha**](https://seekingalpha.com/instablog/12102811-donovan-jones/6092843-hong-kong-pharma-digital-technology-aims-for-5-million-micro-ipo) | [[Digital Health Technologies]]; [[Regulatory Restrictions]]; [[Digital Health]] | | 12/8/2024 | [**Tempus AI: Why I'm Buying This AI Stock - Seeking Alpha**](https://seekingalpha.com/article/4742874-tempus-ai-why-im-buying-this-ai-stock) | [[Genomic Sequencing]]; [[Gynecologic Oncology]]; [[Wearable Health Technology]] | | 11/22/2024 | [**Oracle: Disrupting The Healthcare Industry With AI (NYSE:ORCL) - Seeking Alpha**](https://seekingalpha.com/article/4739668-oracle-disrupting-the-healthcare-industry-with-ai) | [[AI-Driven Predictive Analytics]]; [[Healthcare Communication]]; [[Data Management]] | | 11/13/2024 | [**Tarsus Pharmaceuticals, Inc. (TARS) Q3 2024 Earnings Call Transcript**](https://seekingalpha.com/article/4737179-tarsus-pharmaceuticals-inc-tars-q3-2024-earnings-call-transcript) | [[Patient Education]] | | 11/7/2024 | [**Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'**](https://seekingalpha.com/article/4734829-twist-bioscience-earnings-preview-partnerships-and-valuation-make-it-a-buy) | [[Biopharma]]; [[RNA Sequencing]]; [[Bioinformatics]] | ## Recent Stories (Some LLM-derived content — please confirm with above primary sources) ### Topics Covered - **Salesforce Performance**: Salesforce, Inc. initiated coverage with a 'Buy' recommendation, reporting $9.33 billion in revenue for fiscal Q2 FY2025, an 8% year-over-year increase, driven by AI and data solutions. - **Healthcare Policy Changes**: Anticipated healthcare policy changes under President-elect Trump, including potential increases in Medicare Advantage payment rates and challenges to Medicaid. - **Technological Innovations**: Technological advancements like AI-powered shopping assistants and contactless payments are reshaping consumer behavior, with companies like Twilio and Gap leveraging these trends. - **Crispr Therapeutics Overview**: Crispr Therapeutics reported over $1.9 billion in cash, focusing on gene therapies with promising product candidates and a strong financial outlook despite market challenges. - **Endava's Growth Outlook**: Endava PLC maintains a buy rating despite near-term growth challenges, emphasizing the importance of core modernization and AI adoption. - **Nvidia's Collaborations**: Nvidia partners with life sciences companies to enhance drug discovery and genomics research using generative AI. - **Tempus AI Developments**: Tempus AI reported significant revenue growth and strategic acquisitions, aiming for adjusted EBITDA breakeven by FY2025. - **Palantir's Market Position**: Palantir reported strong revenue growth and secured significant contracts, highlighting its competitive edge in AI deployment. - **J.P. Morgan Healthcare Conference**: The conference showcased optimism for 2025, focusing on regulatory outlook, AI integration, and potential M&A activity in healthcare. - **Bankruptcy Trends**: Bankruptcy filings in the healthcare sector are projected to decrease, although large companies continue to file at elevated levels, particularly in clinics and physician practices. - **Company Highlights**: Ascendis Pharma, Illumina, Daré Bioscience, and others are discussed for their innovative approaches and recent earnings calls. - **Regulatory Impact**: Bristol Myers Squibb and Novartis criticize the U.S. government's Inflation Reduction Act for its impact on drug pricing. - **Simply Good Foods**: The company is positioned to meet rising consumer demand for lean protein and fiber-rich snacks, with brands like Atkins and Quest Nutrition. Recent acquisition of OWYN is expected to enhance product offerings. - **Personalis**: The author emphasizes the potential of the NeXT Platform and discusses investment strategies focused on innovative biotech companies. - **CVC Capital Partners**: A private equity firm specializing in various investment strategies across multiple sectors, including healthcare and technology. - **U.S. Economy and Stock Market Performance**: The S&P 500 saw gains while small and mid-cap indices declined, with technology stocks driving performance amidst high interest rates. - **Healthcare Sector Performance**: The healthcare sector faced challenges despite strong demand for GLP-1 drugs, with mixed performance across various companies. - **UroGen Pharma**: The company is recognized for its innovative treatments for urological cancers, showing promising clinical results. - **AbbVie Inc.**: AbbVie has seen stock growth due to its immunology products and is actively investing in new therapies despite challenges from biosimilars. - **AffyImmune**: The company appointed a new CEO to expedite the development of CAR T cell therapies for cancer treatment. ### Organizations Mentioned - **Salesforce, Inc.**: A cloud-based software company specializing in customer relationship management (CRM). - **Crispr Therapeutics**: A biotechnology company focused on gene editing therapies for various diseases. - **Endava PLC**: A technology company providing IT services and consulting. - **Nvidia**: A technology company known for its graphics processing units (GPUs) and AI computing. - **Tempus AI**: A healthcare technology company specializing in data-driven precision medicine. - **Palantir Technologies**: A software company that specializes in big data analytics. - **J.P. Morgan**: A global financial services firm that hosts an annual healthcare conference. - **Wiley**: An education and academic publishing company. - **OpenTable**: An online restaurant reservation service. - **Oracle**: A multinational computer technology corporation. - **Illumina**: A biotechnology company specializing in genomics. - **IQVIA**: A global provider of advanced analytics, technology solutions, and contract research services. - **Mayo Clinic**: A nonprofit American academic medical center focused on integrated clinical practice, education, and research. - **Healwell AI Inc.**: A Canadian healthcare technology provider focused on AI solutions. - **Cardinal Health, Inc.**: A healthcare services and products company. - **Tempus AI, Inc.**: A healthcare technology company focused on precision medicine. - **Thermo Fisher Scientific**: A provider of laboratory equipment and solutions for scientific research. - **Fidelity**: A financial services corporation known for its investment management and brokerage services. - **Ascendis Pharma A/S**: A biopharmaceutical company based in Copenhagen, Denmark, focusing on advanced therapeutics. - **Illumina, Inc.**: A company specializing in next-generation sequencing and genomic analysis.